312 research outputs found
Recommended from our members
Co-Emergence of Specialized Endothelial Cells from Embryonic Stem Cells.
A well-formed and robust vasculature is critical to the health of most organ systems in the body. However, the endothelial cells (ECs) forming the vasculature can exhibit a number of distinct functional subphenotypes like arterial or venous ECs, as well as angiogenic tip and stalk ECs. In this study, we investigate the in vitro differentiation of EC subphenotypes from embryonic stem cells (ESCs). Using our staged induction methods and chemically defined mediums, highly angiogenic EC subpopulations, as well as less proliferative and less migratory EC subpopulations, are derived. Furthermore, the EC subphenotypes exhibit distinct surface markers, gene expression profiles, and positional affinities during sprouting. While both subpopulations contained greater than 80% VE-cad+/CD31+ cells, the tip/stalk-like EC contained predominantly Flt4+/Dll4+/CXCR4+/Flt-1- cells, while the phalanx-like EC was composed of higher numbers of Flt-1+ cells. These studies suggest that the tip-specific EC can be derived in vitro from stem cells as a distinct and relatively stable EC subphenotype without the benefit of its morphological positioning in the sprouting vessel
Basic and applied uses of genome-scale metabolic network reconstructions of Escherichia coli.
The genome-scale model (GEM) of metabolism in the bacterium Escherichia coli K-12 has been in development for over a decade and is now in wide use. GEM-enabled studies of E. coli have been primarily focused on six applications: (1) metabolic engineering, (2) model-driven discovery, (3) prediction of cellular phenotypes, (4) analysis of biological network properties, (5) studies of evolutionary processes, and (6) models of interspecies interactions. In this review, we provide an overview of these applications along with a critical assessment of their successes and limitations, and a perspective on likely future developments in the field. Taken together, the studies performed over the past decade have established a genome-scale mechanistic understanding of genotype–phenotype relationships in E. coli metabolism that forms the basis for similar efforts for other microbial species. Future challenges include the expansion of GEMs by integrating additional cellular processes beyond metabolism, the identification of key constraints based on emerging data types, and the development of computational methods able to handle such large-scale network models with sufficient accuracy
Multimodal Variational Autoencoders for Semi-Supervised Learning: In Defense of Product-of-Experts
Multimodal generative models should be able to learn a meaningful latent
representation that enables a coherent joint generation of all modalities
(e.g., images and text). Many applications also require the ability to
accurately sample modalities conditioned on observations of a subset of the
modalities. Often not all modalities may be observed for all training data
points, so semi-supervised learning should be possible. In this study, we
evaluate a family of product-of-experts (PoE) based variational autoencoders
that have these desired properties. We include a novel PoE based architecture
and training procedure. An empirical evaluation shows that the PoE based models
can outperform an additive mixture-of-experts (MoE) approach. Our experiments
support the intuition that PoE models are more suited for a conjunctive
combination of modalities while MoEs are more suited for a disjunctive fusion
Analysis of patient results distributions to reevaluate a reference range change for calcium, after a change in assay reagents on the Roche Cobas c500 analyzer
Introduction:
A change in reagents for calcium (Ca) on the Roche Cobas c500 used in our laboratory analyzer took place in 2013. The previous reference range (8.5-10.5 mg/dL) was replaced with that from the manufacturer\u27s study (8.6-10.0 mg/dL), based on correlation of results between the new and old assays. As a matter of quality assurance, we undertook a post-assay-change reevaluation of the reference range change, using a method based on that of Bhattacharya [1]. In short, the method relies on the assumption that the reference range is a normal distribution, which assumption enables this distribution to be isolated mathematically from within all-comers patient distribution data that are not normally distributed
Personalized Whole-Cell Kinetic Models of Metabolism for Discovery in Genomics and Pharmacodynamics
SummaryUnderstanding individual variation is fundamental to personalized medicine. Yet interpreting complex phenotype data, such as multi-compartment metabolomic profiles, in the context of genotype data for an individual is complicated by interactions within and between cells and remains an unresolved challenge. Here, we constructed multi-omic, data-driven, personalized whole-cell kinetic models of erythrocyte metabolism for 24 healthy individuals based on fasting-state plasma and erythrocyte metabolomics and whole-genome genotyping. We show that personalized kinetic rate constants, rather than metabolite levels, better represent the genotype. Additionally, changes in erythrocyte dynamics between individuals occur on timescales of circulation, suggesting detected differences play a role in physiology. Finally, we use the models to identify individuals at risk for a drug side effect (ribavirin-induced anemia) and how genetic variation (inosine triphosphatase deficiency) may protect against this side effect. This study demonstrates the feasibility of personalized kinetic models, and we anticipate their use will accelerate discoveries in characterizing individual metabolic variation
Global Rebalancing of Cellular Resources by Pleiotropic Point Mutations Illustrates a Multi-scale Mechanism of Adaptive Evolution
Pleiotropic regulatory mutations affect diverse cellular processes, posing a challenge to our understanding of genotype-phenotype relationships across multiple biological scales. Adaptive Laboratory Evolution (ALE) allows for such mutations to be found and characterized in the context of clear selection pressures. Here, several ALE-selected single-mutation variants in Escherichia coli's RNA polymerase (RNAP) are detailed using an integrated multi-scale experimental and computational approach. While these mutations increase cellular growth rates in steady environments, they reduce tolerance to stress and environmental fluctuations. We detail structural changes in the RNAP that rewire the transcriptional machinery to rebalance proteome and energy allocation towards growth and away from several hedging and stress functions. We find that while these mutations occur in diverse locations in the RNAP, they share a common adaptive mechanism. In turn, these findings highlight the resource allocation tradeoffs organisms face and suggest how the structure of the regulatory network enhances evolvability
Assessment of utility of daily patient results averages as adjunct quality control in a weekday-only satellite chemistry laboratory
ABSTRACT
Background:
Our department operates a weekday-only (8AM-5PM) satellite laboratory in an infusion center with a menu of 18 chemistry tests on a Roche c501 analyzer. We examined whether daily patient results averages (PRA) in this setting might be useful as a patient-based quality control (PBQC) adjunct to standard daily liquid quality control (LQC) measurements. First, we evaluated the reproducibility (coefficient of variation, CV) of daily PRAs for each analyte, and compared these to CVs of LQC. Second, for select analytes found to have relatively low PRA CVs, we evaluated the extent to which use of daily PRA measurements could improve detection of analytical errors when combined with LQC.
Methods:
Patient results data for approximately one month (21 weekdays) were obtained from the Sunquest laboratory information system. For calculation of patient results averages (PRA), qualifying results were restricted to those within the reference range for each analyte. PRA and standard deviation (S) of PRA across 21 days was calculated for each analyte. Coefficients of variation for PRA (CV-PRA) were compared to those observed for standard liquid quality control (LQC) measurements (CV-LQC). For those analytes for which CV-PRA was less than CV-LQC, we evaluated the potential advantage of addition of PRA to daily LQC. For each analyte, a presumed PRA shift was determined such that probability of detection (P) was 0.5 when using LQC alone (viz., using high LQC and low LQC measurements), according to criterion that at least one 1-2S deviation from mean was obtained. For this same PRA shift, P = 0.5 for LQC alone was compared to P obtained for LQC + PRA (viz., using high LQC, low LQC, and PRA measurements), according to the same criterion.
Results:
Across 21 days, the number of results per day per assay ranged from 23 ±4 (uric acid) to 75 ±21 (electrolytes). Qualifying results (results within the reference range) ranged from 70 ± 6 % (LDH) to 99 ± 1 % (Cl). Seven analytes had CV-PRA \u3c CV-LQC (analyte, CV%): albumin, 1.25%; Ca, 0.67%; Cl, 0.62%; CO2, 1.13%; creatinine, 3.44%; K, 1.14%; Na, 0.65%. The remainder did not meet this criterion: ALP, 3.7%; ALT, 5.2%; AST, 5.1%; BUN, 4.6%; glucose, 1.4%; LDH, 2.0%; Mg, 1.4%; P, 2.5%; protein, 0.9%; TBIL, 6.1%; uric acid, 4.3%. Among the seven analytes for which CV-PRA \u3c CV-LQC, probability (P) of shift detection by LQC for circumstances as described in Methods (LQC P = 0.5) was increased substantially by inclusion of PRA (analyte, shift in analyte concentration, P): CO2, ±1.07 mmol/L, 0.97; creatinine, ±0.099 mg/dL, 0.93; albumin, ±0.126 g/dL, 0.85; Ca, ±0.14 mg/dL, 0.80; K, ±0.097 mmol/L, 0.76; Cl, ±1.24 mmol/L, 0.74; Na, ±1.48 mmol/L, 0.68.
Conclusions:
For 7 analytes, daily PRA demonstrated CVs less than those for LQC. For these analytes, calculations demonstrated that daily PRA can increase probability of detection of small results shifts when used as an adjunct to LQC. Daily PRA is a simple and essentially cost-free form of PBQC that may be useful for certain analytes in part-time laboratory settings
Modeling Method for Increased Precision and Scope of Directly Measurable Fluxes at a Genome-Scale
Metabolic flux analysis (MFA) is
considered to be the gold standard
for determining the intracellular flux distribution of biological
systems. The majority of work using MFA has been limited to core models
of metabolism due to challenges in implementing genome-scale MFA and
the undesirable trade-off between increased scope and decreased precision
in flux estimations. This work presents a tunable workflow for expanding
the scope of MFA to the genome-scale without trade-offs in flux precision.
The genome-scale MFA model presented here, iDM2014, accounts for 537
net reactions, which includes the core pathways of traditional MFA
models and also covers the additional pathways of purine, pyrimidine,
isoprenoid, methionine, riboflavin, coenzyme A, and folate, as well
as other biosynthetic pathways. When evaluating the iDM2014 using
a set of measured intracellular intermediate and cofactor mass isotopomer
distributions (MIDs), it was found that
a total of 232 net fluxes of central and peripheral metabolism could
be resolved in the <i>E. coli</i> network. The increase
in scope was shown to cover the full biosynthetic route to an expanded
set of bioproduction pathways, which should facilitate applications
such as the design of more complex bioprocessing strains and aid in
identifying new antimicrobials. Importantly, it was found that there
was no loss in precision of core fluxes when compared to a traditional
core model, and additionally there was an overall increase in precision
when considering all observable reactions
- …